GRI Bio, Inc. (GRI) NASDAQ

0.54

+0.0066(+1.24%)

Updated at February 05 03:01PM

Currency In USD

Valuation

Market Cap14.91M
Enterprise Value13.12M
P/E Ratio-0.21
PEG Ratio-0.01
Price/Sales Ratio0.89
Price/Book Ratio0.47
Enterprise/Revenue0.04
Enterprise/EBITDA-0.03

Fiscal Year

Fiscal YearDecember 31, 2023
Most Recent QuarterOctober 31, 2024

Profitability

Profit Margin-1.53
Operating Margin-1.54

Management Effectiveness

Return On Assets-1.51
Return On Equity-2.89

Income Statement

Revenue21.77M
Revenue/Share1.71
Gross Profit21.71M
EBITDA-10.9M
Net Income-13.04M
Diluted EPS-28.25

Balance Sheet

Total Cash4.75M
Total Cash/Share1.5
Total Debt131,000
Total Debt/Equity0.04
Current Ratio3.1
Book Value Per Share1.16

Price History

52-Week Change-96.85
52-Week High21.06
52-Week Low0.3
Moving Average 50 Days0.74
Moving Average 200 Days1.72

Statistics

Average Volume303,800
Shares Outstanding8.93M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:13
Last Split DateJune 18, 2024